Article Details

Immunity-centric biotech firm lands $60m in Series A funding

Retrieved on: 2021-02-11 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Immunity-centric biotech firm lands $60m in Series A funding. View article details on hiswai:

Excerpt

Immunai's technology integrates multi-omic single-cell analytics and machine learning (ML) to identify novel immunological insights, in the hopes of ...

Article found on: www.outsourcing-pharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up